United Therapeutics (UTHR) CFO sells 10K shares after option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
United Therapeutics Corp CFO and Treasurer James Edgemond reported an exercise-and-sell transaction in company stock. On May 7, 2026, he exercised stock options to acquire 10,000 shares of Common Stock at an exercise price of $135.42 per share and sold 10,000 shares of Common Stock in a series of open-market sales at prices around the high-$500 range per share. The filing notes that the option exercise and subsequent sales were carried out under a pre-arranged Rule 10b5-1 trading plan, indicating the trades were scheduled in advance rather than timed discretionarily.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares ($5,785,775)
Net Sell
20 txns
Insider
EDGEMOND JAMES
Role
CFO AND TREASURER
Sold
10,000 shs ($5.79M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 10,000 | $0.00 | -- |
| Exercise | Common Stock | 10,000 | $135.42 | $1.35M |
| Sale | Common Stock | 560 | $569.7093 | $319K |
| Sale | Common Stock | 560 | $571.7658 | $320K |
| Sale | Common Stock | 807 | $572.9273 | $462K |
| Sale | Common Stock | 1,306 | $573.9442 | $750K |
| Sale | Common Stock | 1,045 | $575.1369 | $601K |
| Sale | Common Stock | 1,002 | $575.9782 | $577K |
| Sale | Common Stock | 640 | $577.4182 | $370K |
| Sale | Common Stock | 520 | $578.6469 | $301K |
| Sale | Common Stock | 399 | $580.3662 | $232K |
| Sale | Common Stock | 281 | $581.4999 | $163K |
| Sale | Common Stock | 200 | $583.4068 | $117K |
| Sale | Common Stock | 400 | $584.2061 | $234K |
| Sale | Common Stock | 640 | $585.833 | $375K |
| Sale | Common Stock | 340 | $586.7347 | $199K |
| Sale | Common Stock | 700 | $587.7406 | $411K |
| Sale | Common Stock | 320 | $589.0238 | $188K |
| Sale | Common Stock | 120 | $589.7233 | $71K |
| Sale | Common Stock | 160 | $597.54 | $96K |
Holdings After Transaction:
Stock Option — 22,500 shares (Direct, null);
Common Stock — 28,876 shares (Direct, null)
Footnotes (1)
- This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. This transaction was executed in multiple trades at prices ranging from $569.69 to $569.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $571.39 to $572.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $572.49 to $573.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $573.52 to $574.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $574.60 to $575.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $575.60 to $576.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $577.00 to $577.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $578.36 to $579.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $579.65 to $580.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $580.77 to $581.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $582.62 to $583.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $583.92 to $584.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $585.25 to $586.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $586.42 to $587.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $587.46 to $588.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $588.53 to $589.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $589.70 to $589.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Options exercised: 10,000 shares
Option exercise price: $135.42/share
+5 more
8 metrics
Shares sold
10,000 shares
Total Common Stock sold in open-market transactions on May 7, 2026
Options exercised
10,000 shares
Common Stock underlying options exercised on May 7, 2026
Option exercise price
$135.42/share
Exercise price for stock options converted into Common Stock
Highest sale price shown
$597.54/share
Price for a portion of Common Stock sold in open-market trade
Lowest sale price shown
$569.71/share
Representative low sale price from reported transactions
Rule 10b5-1 plan date
October 31, 2025
Date the CFO entered the trading plan governing these trades
Option expiration
March 15, 2027
Expiration date of stock options exercised for 10,000 shares
Exercise date of option grant
March 15, 2023
Listed exercise date associated with the stock option award
Key Terms
Rule 10b5-1 trading plan, stock options, open-market sale, derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What did United Therapeutics (UTHR) CFO James Edgemond report in this Form 4?
He reported exercising options for 10,000 United Therapeutics shares and selling 10,000 shares in open-market transactions, all on May 7, 2026, as part of a pre-arranged Rule 10b5-1 trading plan.
What stock options did the United Therapeutics (UTHR) CFO exercise?
He exercised stock options covering 10,000 shares of United Therapeutics Common Stock at an exercise price of $135.42 per share, converting a derivative position into directly held shares before executing related open-market sales.